Zhen Teng Liu
Algemeen Directeur bij SHANDONG LUOXIN PHARMACY GROUP CO LTD
Vermogen: 3 M $ op 30-04-2024
Actieve functies van Zhen Teng Liu
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| SHANDONG LUOXIN PHARMACY GROUP CO LTD | Voorzitter | 23-04-2020 | - |
| Algemeen Directeur | 31-01-2023 | - | |
| Directeur/Bestuurslid | 01-07-2013 | 23-04-2020 | |
| LUOXIN PHARMACEUTICALS GROUP STOCK CO., LTD. | Algemeen Directeur | 23-04-2023 | - |
| Voorzitter | 23-04-2020 | - |
Loopbaan van Zhen Teng Liu
Opleiding van Zhen Teng Liu
| Macquarie University | Undergraduate Degree |
| The University of New South Wales | Masters Business Admin |
Statistieken
Internationaal
| China | 3 |
| Australië | 3 |
Operationeel
| Chairman | 2 |
| Chief Executive Officer | 2 |
| Director/Board Member | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| LUOXIN PHARMACEUTICALS GROUP STOCK CO., LTD. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.
 Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. Pharmaceuticals: MajorHealth Technology Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. engages in the manufacture, sale, research and development of pharmaceutical products. Its products include anti-infective, antiviral, respiratory system, digestive system, nervous, endocrine, cardiovascular system, antipyretic, analgesics & anti-inflammatory, oncology, anti-allergic APIs & intermediates, lyophilized powder for injection preparation, solid preparation, chemical raw medicine, cephalosporin raw medicine and oral cephalosporin series. The company was founded on May 05, 1998 and is headquartered in Linyi, China. | Health Technology |
- Beurs
- Insiders
- Zhen Teng Liu
- Ervaring
